LLY

764

+2.13%↑

JNJ

176.45

-0.55%↓

ABBV

216.08

-0.77%↓

UNH

339.82

-2.33%↓

AZN

77.61

-0.58%↓

LLY

764

+2.13%↑

JNJ

176.45

-0.55%↓

ABBV

216.08

-0.77%↓

UNH

339.82

-2.33%↓

AZN

77.61

-0.58%↓

LLY

764

+2.13%↑

JNJ

176.45

-0.55%↓

ABBV

216.08

-0.77%↓

UNH

339.82

-2.33%↓

AZN

77.61

-0.58%↓

LLY

764

+2.13%↑

JNJ

176.45

-0.55%↓

ABBV

216.08

-0.77%↓

UNH

339.82

-2.33%↓

AZN

77.61

-0.58%↓

LLY

764

+2.13%↑

JNJ

176.45

-0.55%↓

ABBV

216.08

-0.77%↓

UNH

339.82

-2.33%↓

AZN

77.61

-0.58%↓

Search

Viatris Inc

Chiusa

SettoreSettore sanitario

9.55 -0.42

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

9.49

Massimo

9.64

Metriche Chiave

By Trading Economics

Entrata

3B

-4.6M

Vendite

328M

3.6B

Rendimento da dividendi

4.57

Margine di Profitto

-0.128

Dipendenti

32,000

EBITDA

2.9B

578M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+5.21% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

4.57%

3.12%

Utili prossimi

6 nov 2025

Prossima data del Dividendo

12 dic 2025

Prossima data del' Ex Dividendo

21 nov 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

1.7B

12B

Apertura precedente

9.97

Chiusura precedente

9.55

Notizie sul Sentiment di mercato

By Acuity

50%

50%

183 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

Viatris Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

15 set 2025, 22:39 UTC

Acquisizioni, Fusioni, Takeovers

CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer

15 set 2025, 16:43 UTC

I principali Market Mover

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

15 set 2025, 16:42 UTC

I principali Market Mover

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

15 set 2025, 16:35 UTC

I principali Market Mover

Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process

15 set 2025, 23:46 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

15 set 2025, 23:46 UTC

Discorsi di Mercato

Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk

15 set 2025, 23:34 UTC

Discorsi di Mercato

Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk

15 set 2025, 22:48 UTC

Discorsi di Mercato

FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk

15 set 2025, 22:12 UTC

Acquisizioni, Fusioni, Takeovers

CSL Expects Commercial Launch in 2029

15 set 2025, 22:12 UTC

Acquisizioni, Fusioni, Takeovers

CSL Says VarmX to Receive Further Commercial Milestones Afterwards

15 set 2025, 22:11 UTC

Acquisizioni, Fusioni, Takeovers

CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001

15 set 2025, 22:11 UTC

Acquisizioni, Fusioni, Takeovers

CSL to Have Right to Exercise Option Based on Phase 3 Data

15 set 2025, 22:10 UTC

Acquisizioni, Fusioni, Takeovers

CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company

15 set 2025, 21:16 UTC

Acquisizioni, Fusioni, Takeovers

Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital

15 set 2025, 21:16 UTC

Acquisizioni, Fusioni, Takeovers

Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development

15 set 2025, 21:15 UTC

Acquisizioni, Fusioni, Takeovers

Chord Energy to Buy 48,000 Net Acres in the Williston Core

15 set 2025, 21:14 UTC

Acquisizioni, Fusioni, Takeovers

Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M

15 set 2025, 20:50 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

15 set 2025, 20:50 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

15 set 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

15 set 2025, 19:29 UTC

Discorsi di Mercato

U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk

15 set 2025, 19:14 UTC

Discorsi di Mercato

Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk

15 set 2025, 18:16 UTC

Discorsi di Mercato

Gold Powers to New High -- Market Talk

15 set 2025, 18:05 UTC

Discorsi di Mercato

Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk

15 set 2025, 17:50 UTC

Acquisizioni, Fusioni, Takeovers

U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update

15 set 2025, 17:10 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

15 set 2025, 17:10 UTC

Discorsi di Mercato

S&P Expects Fed, BOC to Cut Rates -- Market Talk

15 set 2025, 16:52 UTC

Discorsi di Mercato

Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk

15 set 2025, 16:20 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

15 set 2025, 16:20 UTC

Discorsi di Mercato
Utili

Auto & Transport Roundup: Market Talk

Confronto tra pari

Modifica del prezzo

Viatris Inc Previsione

Obiettivo di Prezzo

By TipRanks

5.21% in crescita

Previsioni per 12 mesi

Media 10.1 USD  5.21%

Alto 14 USD

Basso 8 USD

Basato su 5 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Viatris Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

5 ratings

0

Acquista

4

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

8.48 / N/ASupporto e resistenza

A breve termine

Bullish Evidence

A termine intermedio

Very Strong Bullish Evidence

A lungo termine

Strong Bearish Evidence

Sentiment

By Acuity

183 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Viatris Inc

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
help-icon Live chat